United Therapeutics Corporation (UTHR) vs Viatris Inc. (VTRS)
- United Therapeutics Corporation UTHR 533.12 −1.55%
- Viatris Inc. VTRS 18.66 +2.41%
United Therapeutics Corporation and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. United Therapeutics Corporation is the larger, with a market value of $23.2B against $20.9B — 1.1× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; United Therapeutics Corporation trades at 17.6×. Viatris Inc. grew revenue faster over the last twelve months: 4.40% against 2.49%. United Therapeutics Corporation has the higher net margin (41.6% vs −2.79%) and the higher return on invested capital (23.4% vs −0.20%). Across the 21 metrics below, United Therapeutics Corporation leads on 14 and Viatris Inc. on 7.
Valuation
Profitability
| Metric | UTHR | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 86.14% | 34.83% | 53.94% |
| Operating margin | 44.44% | (0.59%) | 0.00% |
| Net margin | 41.56% | (2.79%) | 0.00% |
| Free cash flow margin | 34.65% | 12.83% | 0.00% |
| Return on equity | 19.32% | (2.75%) | (0.40%) |
| Return on assets | 17.33% | (1.12%) | (3.32%) |
| Return on invested capital | 23.44% | (0.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack